Develops a two-component transcatheter mitral valve replacement system for patients with mitral regurgitation who are not surgical candidates. The system and its Clarity Valve carry CE marks granted in 2026.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.